Newsletter logo   Search News     Daily News   

Published:

Synthetech Announces Date for Second Quarter Fiscal 2010 Earnings Release and Conference Call

ALBANY, Ore., Nov. 4 /PRNewswire-FirstCall/ -- Synthetech, Inc. (OTC Bulletin Board: NZYM) today announced it will issue second quarter financial results before the opening of the market on Tuesday, November 10, 2009. Following the release of its financial results, Synthetech will host a conference call at 1:30 p.m. PST. Dr. Gregory Hahn, President and CEO, along with Gary Weber, Vice President of Finance and CFO, will discuss results and be available to answer related questions.

The conference call can be accessed by dialing 877-524-1203 at 1:15 p.m. PST and entering code 413413. Replays of the audio only conference will be available after the call via the investor area of Synthetech's website at www.synthetech.com.

About Synthetech

Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and proprietary custom chiral intermediates and specialty resins, primarily for the pharmaceutical industry. Synthetech produces advanced pharmaceutical intermediates in accordance with Current Good Manufacturing Practices (cGMP) in compliance with U.S. Food and Drug Administration (FDA) regulations. Our products support the development and manufacture of therapeutic peptides and peptidomimetic (peptide-like) small molecule drugs from early stages of a customer's clinical development through market launch and into commercial production. Synthetech's products also support the production of chemically-based medical devices. Synthetech's domestic and international customer base includes major pharmaceutical, contract drug synthesis firms, emerging biotechnology (virtual pharmaceutical) and medical device companies. We also supply catalog quantities of specialty amino acids to research institutions, universities and drug discovery firms.

    MORE INFORMATION:  Web site: www.synthetech.com
                       E-mail: investor@synthetech.com

    CONTACT:           Gary Weber, CFO
                       PO Box 646
                       Albany, Oregon  97321
                       541 967-6575

SOURCE Synthetech, Inc.

Tags: ,CHM,NAN,OTC,CCA,OR-Synthetech-Call

  care2 logo  digg logo  
 

Be Interviewed today

Editorial Cartoons
Political Cartoons

newsletter logo
Get Chitika Premium



Sponsor Links:

Writers Wanted
Help NewsBlaze provide daily news, including top stories, Home and Garden, Technology, The Environment and more. NewsBlaze Writer
Relevant Sites:
NewsBlaze 
Copyright © 2004-2009 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy       Support    Press Room